Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04708054
Title Venetoclax, Busulfan, Cladribine, and Fludarabine for the Treatment of High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

myelodysplastic syndrome

chronic myelomonocytic leukemia

acute myeloid leukemia


Busulfan + Cladribine + Fludarabine + Thiotepa + Venetoclax

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST